Beta-blockers can be discussed as one of the approaches to limit chronic kidney disease progression, as well as to prevent cardiovascular complications in this patients. Therapeutic opportunities of beta-blockers should be explained by their effects on pathological sympathetic overactivation.

Keywords: sympathetic overactivation, chronic renal failure, cardio-renal syndrome, beta-blockers, arterial hypertension